drugset / Trial / NCT03457025

Effect of Adjuvant Hyperbaric Oxygen Therapy on Bells Palsy Outcome

NCT03457025

Phase 0 Withdrawn NYU Langone Health
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized, single blinded, non-placebo controlled that will compare one group of Bells Palsy patients receiving the current standard of care including oral corticosteroids and oral antivirals against an experimental group receiving the current standard of care in addition to hyperbaric oxygen therapy. Outcome assessment will be based on both objective analyses of facial movements as well as subjective quality of life scales.

Timeline

Start
2019-08
Primary completion
2020-06
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Background Acyclovir Small molecule 400 mg Oral
Background Prednisone Other / unclassified 60 mg Oral

Indications